| [1] | Hou YiXin, Zhang Qun, Yang ZhiYun, Yang YuYing, Jiang YuYong, Wang XianBo. Effect of spleen-strengthening, dampness-removing, and hemostatic prescription on rebleeding within one year in cirrhotic patients with esophagogastric variceal bleeding[J]. Journal of Clinical Hepatology, 2018, 34(10): 2136-2141. doi: 10.3969/j.issn.1001-5256.2018.10.015 |
| [2] | Xiao HuanMing, Zhang QiPeng, Shi MeiJie, Yang YuQi, Liu LeXin, Li Sheng, Chi XiaoLing. Clinical effect of chronic disease management with traditional Chinese medicine characteristics in community patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2018, 34(8): 1669-1673. doi: 10.3969/j.issn.1001-5256.2018.08.015 |
| [3] | Hepatobiliary Specialized Committee of China Association of Chinese Medicine, Liver Diseases Specialized Committee of China Medical Associa- tion of Minorities. The clinical guidelines of diagnosis and treatment of chronic hepatitis B with traditional Chinese medicine(2018)[J]. Journal of Clinical Hepatology, 2018, 34(12): 2520-2525. doi: 10.3969/j.issn.1001-5256.2018.12.007 |
| [4] | Branch of Gastrointestinal Diseases, China Association of Chinese Medicine. Expert consensus on TCM diagnosis and treatment of nonalcoholic fatty liver disease (2017)[J]. Journal of Clinical Hepatology, 2017, 33(12): 2270-2274. doi: 10.3969/j.issn.1001-5256.2017.12.002 |
| [5] | Li Qiang, Zhuo QiBin, Huang YuXian, Chen Liang. Clinical features of acute hepatitis B and acute exacerbation of chronic hepatitis B: a comparative study[J]. Journal of Clinical Hepatology, 2016, 32(4): 706-710. doi: 10.3969/j.issn.1001-5256.2016.04.019 |
| [6] | Ruan JianWen, Gao LiJuan, Su RuKai. Clinical features of patients with acute exacerbation of chronic hepatitis B: an analysis of 74 cases[J]. Journal of Clinical Hepatology, 2016, 32(11): 2096-2098. doi: 10.3969/j.issn.1001-5256.2016.11.017 |
| [7] | Zhang ZeTian, Ji HuiFan, Chen Shuai, Li Xu, Yang WenXuan, Zhang GuoShan, Guo XiaoLin. Clinical cure of chronic hepatitis B: a case report[J]. Journal of Clinical Hepatology, 2016, 32(8): 1578-1579. doi: 10.3969/j.issn.1001-5256.2016.08.030 |
| [8] | Xiao ChunYang, Li QinKai, Yu JingXia, Liu Ting, Lu LunGen, Xu MingYi. Risk genes for the development of chronic hepatitis B cirrhosis assessed by prediction analysis of microarrays[J]. Journal of Clinical Hepatology, 2016, 32(7): 1323-1329. doi: 10.3969/j.issn.1001-5256.2016.07.022 |
| [9] | Xun YunHao, Guo JianChun. Clinical application of traditional Chinese medicine constitution theory in diagnosis and treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(4): 644-648. doi: 10.3969/j.issn.1001-5256.2016.04.006 |
| [10] | Gao YueQiu. Strategy for traditional Chinese medicine prevention and treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2015, 31(1): 35-37. doi: 10.3969/j.issn.1001-5256.2015.01.008 |
| [11] | Zhu QiRong. Nosocomial infections and chronic severe hepatitis B: A clinical study of 162 patients[J]. Journal of Clinical Hepatology, 2012, 28(7): 525-527. |
| [12] | Li ChunXia, Pan HuaiQiang, Li YanJun, Xu GuangHua, Chen YanPing, Feng JiHong, Wei Hua, Ceng QingLei. One case report of occult hepatitis B infection[J]. Journal of Clinical Hepatology, 2012, 28(1): 66-68. |
| [13] | Zhang Tao, Sun KeWei. Experience and progresses of Chinese medicine therapy for hepatitis B-associated liver failure[J]. Journal of Clinical Hepatology, 2012, 28(3): 169-171+182. |
| [14] | Lei RenGuo, Tang HongLi, Ma YuTing, Jiang ChunHua, Fu XiaoFan. The recent study of traditional Chinese medicine intervention with the side effects of interferon for treatment of patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2012, 28(3): 236-237+241. |
| [15] | Niu ChunYan, Zheng JianYun, Li Lei, Gao BaoHua, Liu Bing, Luo JianMei. The expression and significance of HMGB1 in chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(8): 807-809. |
| [16] | Yang Song, Cheng Jun. Interpretation of Chinese guideline on prevention and treatment for chronic hepatitis B (2011version) -status quo and prospect of antiviral therapy[J]. Journal of Clinical Hepatology, 2011, 27(8): 794-795+800. |
| [17] | Qiu YingFeng, Ding YongGang, Li GuangMing. Analysis of therapeutic effect of adefovir dipivoxil in continued treatment of chronic hepatitis B patients with poor early virological response to initial treatment[J]. Journal of Clinical Hepatology, 2011, 27(6): 611-613. |
| [18] | Huang WeiShen, Yang Li. Predicting scoring system for hepatocellular carcinoma development in chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2011, 27(4): 363-364. |
| [19] | Li Hai, Jia JiDong. Interpretation of the guideline on prevention and treatment for chronic hepatitis B (2010 version) -the goals and indications for chronic hepatitis B treatment[J]. Journal of Clinical Hepatology, 2011, 27(8): 791-793. |
| [20] | Li Zhi, Yan HongMei, Xue FaXuan, Wang Tong, Liang Qun, Xu Huan, Li ZhangChun. Short-term clinical effect of telbivudine in the treatment chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(6): 420-421+426. |
DownLoad: